Abivax annual current ratio
2021
2022
2023
2024
2025
Abivax Current Ratio Growth & History (ABVX)
Abivax's current ratio was 8.75 for fiscal 2025.
View full Abivax company overviewAbivax annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.75 | 6.93 | +381.75% |
| 2024 | 2024-12-31 | 1.82 | −1.34 | −42.42% |
| 2023 | 2023-12-31 | 3.15 | 2.45 | +348.50% |
| 2022 | 2022-12-31 | 0.70 | −1.64 | −69.95% |
| 2021 | 2021-12-31 | 2.34 | — | — |
Abivax quarterly current ratio
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | 8.25 | 6.99 | +557.30% |
| Q4 2025 | 2025-12-31 | 8.75 | 6.93 | +381.75% |
| Q3 2025 | 2025-09-30 | 7.86 | — | — |
| Q2 2025 | 2025-06-30 | 0.77 | — | — |
| Q1 2025 | 2025-03-31 | 1.25 | — | — |
| Q4 2024 | 2024-12-31 | 1.82 | — | — |
Abivax current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Abivax's current ratio increased from 2.34 to 8.75, a change of 6.41. The latest reported quarter, Q1 2026, shows 8.25.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abivax source filings ↗